Date | Title | Description | |
---|---|---|---|
10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
10 Jan 2022 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 3 January 2022 and 7 January 2022 | Download |
03 Jan 2022 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 27 December 2021 and 31 December 2021 | Download |
28 Dec 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 20 December 2021 and 24 December 2021 | Download |
20 Dec 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 13 December 2021 and 17 December 2021 | Download |
17 Dec 2021 | On business and financial situation | ROVI reports that the CHMP has issued a positive opinion on Okedi® for the treatment for schizophrenia | Download |
Pages
Date | Title | Description | |
---|---|---|---|
06 Nov 2018 | Información sobre resultados | ROVI releases the presentation related to the nine-month period ended 30 September 2018 results. | Download |
06 Nov 2018 | Información sobre resultados | ROVI releases the press release related to the nine-month period ended 30 September 2018 results. | Download |
17 Oct 2018 | Buy-back programmes, stabilisation and treasury stock | ROVI informs of the resumption of operations with own shares under the liquidity contract | Download |
17 Oct 2018 | Buy-back programmes, stabilisation and treasury stock | ROVI informs that Jefferies International Limited has exercised, in full, the greenshoe subscription option | Download |
08 Oct 2018 | Share capital increases and reductions | Information on new shares admissions related to the capital increase of ROVI | Download |